Sequences in gibbon ape leukemia virus envelope that confer sensitivity to HIV-1 accessory protein Vpu

Journal of Virology

Volumn 85, Issue 22, 2011, Pages 11945-11954

  Janaka, Sanath Kumar ^a   Lucas, Tiffany M ^a   Johnson, Marc C ^a  

^a University of Missouri   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE PROTEIN; PROTEIN CD4; UNCLASSIFIED DRUG; VPU PROTEIN;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ARTICLE; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; CYTOPLASMIC TAIL DOMAIN; GENE MUTATION; GIBBON LEUKEMIA VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; MUTAGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN MOTIF; PROTEIN TARGETING; ROUS SARCOMA ONCOVIRUS; SEQUENCE ANALYSIS; VIRUS ENVELOPE;

DNA MUTATIONAL ANALYSIS; FRIEND MURINE LEUKEMIA VIRUS; HIV-1; HUMAN IMMUNODEFICIENCY VIRUS PROTEINS; HUMANS; LEUKEMIA VIRUS, GIBBON APE; MUTANT PROTEINS; RECOMBINATION, GENETIC; VIRAL ENVELOPE PROTEINS; VIRAL REGULATORY AND ACCESSORY PROTEINS;

FRIEND MURINE LEUKEMIA VIRUS; GAMMARETROVIRUS; GIBBON APE LEUKEMIA VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; ROUS SARCOMA VIRUS;

EID: 80655125487     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.05171-11     Document Type: Article

References (51)

1. Binette, J., et al. 2007. Requirements for the selective degradation of CD4 receptor molecules by the human immunodeficiency virus type 1 Vpu protein in the endoplasmic reticulum. Retrovirology 4:75.
2. Bouard, D., et al. 2007. An acidic cluster of the cytoplasmic tail of the RD114 virus glycoprotein controls assembly of retroviral envelopes. Traffic 8:835-847.
3. Boussif, O., et al. 1995. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc. Natl. Acad. Sci. U. S. A. 92:7297-7301.
4. Bryson, K., et al. 2005. Protein structure prediction servers at University College London. Nucleic Acids Res. 33:W36-W38.
5. Chesebro, B., K. Wehrly, J. Nishio, and S. Perryman. 1992. Macrophagetropic human immunodeficiency virus isolates from different patients exhibit unusual V3 envelope sequence homogeneity in comparison with T-celltropic isolates: definition of critical amino acids involved in cell tropism. J. Virol. 66:6547-6554.
6. Christodoulopoulos, I., and P. M. Cannon. 2001. Sequences in the cytoplasmic tail of the gibbon ape leukemia virus envelope protein that prevent its incorporation into lentiviral vectors. J. Virol. 75:4129-4138.
7. Christodoulopoulos, I., M. E. Droniou-Bonzom, J. E. Oldenburg, and P. M. Cannon. 2010. Vpu-dependent block to incorporation of GaLV Env into lentiviral vectors. Retrovirology 7:4.
8. Douglas, J. L., K. Viswanathan, M. N. McCarroll, J. K. Gustin, K. Fruh, and A. V. Moses. 2009. Vpu directs the degradation of the human immunodeficiency virus restriction factor BST-2/tetherin via a βTrCP-dependent mechanism. J. Virol. 83:7931-7947.
9. Dubé, M., et al. 2010. Antagonism of tetherin restriction of HIV-1 release by Vpu involves binding and sequestration of the restriction factor in a perinuclear compartment. PLoS Pathog. 6:e1000856.
10. Fitzpatrick, K., et al. 2010. Direct restriction of virus release and incorporation of the interferon-induced protein BST-2 into HIV-1 particles. PLoS Pathog. 6:e1000701.
11. Hsu, K., J. Seharaseyon, P. Dong, S. Bour, and E. Marbán. 2004. Mutual functional destruction of HIV-1 Vpu and host TASK-1 channel. Mol. Cell 14:259-267.
12. Hussain, A., C. Wesley, M. Khalid, A. Chaudhry, and S. Jameel. 2008. Human immunodeficiency virus type 1 Vpu protein interacts with CD74 and modulates major histocompatibility complex class II presentation. J. Virol. 82:893-902.
13. Januszeski, M. M., P. M. Cannon, D. Chen, Y. Rozenberg, and W. F. Anderson. 1997. Functional analysis of the cytoplasmic tail of Moloney murine leukemia virus envelope protein. J. Virol. 71:3613-3619.
14. Johnson, M. C. 2011. Mechanisms for Env glycoprotein acquisition by retroviruses. AIDS Res. Hum. Retroviruses 27:239-247.
15. Jones, D. T. 1999. Protein secondary structure prediction based on positionspecific scoring matrices. J. Mol. Biol. 292:195-202.
16. Kerkau, T., et al. 1997. The human immunodeficiency virus type 1 (HIV-1) Vpu protein interferes with an early step in the biosynthesis of major histocompatibility complex (MHC) class I molecules. J. Exp. Med. 185:1295-1305.
17. Kobinger, G. P., D. J. Weiner, Q.-C. Yu, and J. M. Wilson. 2001. Filoviruspseudotyped lentiviral vector can efficiently and stably transduce airway epithelia in vivo. Nat. Biotechnol. 19:225-230.
18. Lenburg, M. E., and N. R. Landau. 1993. Vpu-induced degradation of CD4: requirement for specific amino acid residues in the cytoplasmic domain of CD4. J. Virol. 67:7238-7245.
19. Levesque, K., Y.-S. Zhao, and E. A. Cohen. 2003. Vpu exerts a positive effect on HIV-1 infectivity by down-modulating CD4 receptor molecules at the surface of HIV-1 producing cells. J. Biol. Chem. 278:28346-28353.
20. Lewis, B. C., N. Chinnasamy, R. A. Morgan, and H. E. Varmus. 2001. Development of an avian leukosis-sarcoma virus subgroup A pseudotyped lentiviral vector. J. Virol. 75:9339-9344.
21. Lucas, T. M., T. D. Lyddon, P. M. Cannon, and M. C. Johnson. 2010. Pseudotyping incompatibility between HIV-1 and gibbon ape leukemia virus Env is modulated by Vpu. J. Virol. 84:2666-2674.
22. Magadán, J. G., et al. 2010. Multilayered mechanism of CD4 downregulation by HIV-1 Vpu involving distinct ER retention and ERAD targeting steps. PLoS Pathog. 6:e1000869.
23. Margottin, F., et al. 1998. A novel human WD protein, h-beta TrCp, that interacts with HIV-1 Vpu connects CD4 to the ER degradation pathway through an F-box motif. Mol. Cell 1:565-574.
24. Merten, C. A., et al. 2005. Directed evolution of retrovirus envelope protein cytoplasmic tails guided by functional incorporation into lentivirus particles. J. Virol. 79:834-840.
25. Mitchell, R. S., et al. 2009. Vpu antagonizes BST-2-mediated restriction of HIV-1 release via beta-TrCP and endo-lysosomal trafficking. PLoS Pathog. 5:e1000450.
26. Moll, M., S. K. Andersson, A. Smed-Sörensen, and J. K. Sandberg. 2010. Inhibition of lipid antigen presentation in dendritic cells by HIV-1 Vpu interference with CD1d recycling from endosomal compartments. Blood 116:1876-1884.
27. Neil, S. J. D., T. Zang, and P. D. Beiniasz. 2008. Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. Nature 451:425-430.
28. Pace, C. N., and J. M. Scholtz. 1998. A helix propensity scale based on experimental studies of peptides and proteins. Biophys. J. 75:422-427.
29. Palù, G., C. Parolin, Y. Takeuchi, and M. Pizzato. 2000. Progress with retroviral gene vectors. Rev. Med. Virol. 10:185-202.
30. Paul, M., S. Mazumder, N. Raja, and M. A. Jabbar. 1998. Mutational analysis of the human immunodeficiency virus type 1 Vpu transmembrane domain that promotes the enhanced release of virus-like particles from the plasma membrane of mammalian cells. J. Virol. 72:1270-1279.
31. Perez-Caballero, D., et al. 2009. Tetherin inhibits HIV-1 release by directly tethering virions to cells. Cell 139:499-511.
32. Pinter, A., and W. J. Honnen. 1983. Topography of murine leukemia virus envelope proteins: characterization of transmembrane components. J. Virol. 46:1056-1060.
33. Sarngadharan, M. G., M. Popovic, L. Bruch, J. Schüpbach, and R. C. Gallo. 1984. Antibodies reactive with human T-lymphotropic retroviruses (HTLVIII) in the serum of patients with AIDS. Science 224:506-508.
34. Schubert, U., et al. 1998. CD4 glycoprotein degradation induced by human immunodeficiency virus type 1 Vpu protein requires the function of proteasomes and the ubiquitin-conjugating pathway. J. Virol. 72:2280-2288.
35. Schubert, U., et al. 1996. The two biological activities of human immunodeficiency virus type 1 Vpu protein involve two separable structural domains. J. Virol. 70:809-819.
36. Schubert, U., and K. Strebel. 1994. Differential activities of the human immunodeficiency virus type 1-encoded Vpu protein are regulated by phosphorylation and occur in different cellular compartments. J. Virol. 68:2260-2271.
37. Shah, A. H., et al. 2010. Degranulation of natural killer cells following interaction with HIV-1-infected cells is hindered by downmodulation of NTB-A by Vpu. Cell Host Microbe 8:397-409.
38. Stitz, J., N. Wolfrum, C. J. Buchholz, and K. Cichutek. 2006. Envelope proteins of spleen necrosis virus form infectious human immunodeficiency virus type 1 pseudotype vector particles, but fail to incorporate upon substitution of the cytoplasmic domain with that of gibbon ape leukemia virus. J. Gen. Virol. 87:1577-1581.
39. Stitz, J., et al. 2000. Lentiviral vectors pseudotyped with envelope glycoproteins derived from gibbon ape leukemia virus and murine leukemia virus 10A1. Virology 273:16-20.
40. Strebel, K., T. Klimkait, and M. A. Martin. 1988. A novel gene of HIV-1, vpu, and its 16-kilodalton product. Science 241:1221-1223.
41. Tanaka, M., et al. 2003. Downregulation of CD4 is required for maintenance of viral infectivity of HIV-1. Virology 311:316-325.
42. Tarlinton, R., J. Meers, and P. Young. 2008. Biology and evolution of the endogenous koala retrovirus. Cell. Mol. Life Sci. 65:3413-3421.
43. Taylor, G. M., and D. A. Sanders. 2003. Structural criteria for regulation of membrane fusion and virion incorporation by the murine leukemia virus TM cytoplasmic domain. Virology 312:295-305.
44. Tiganos, E., et al. 1998. Structural and functional analysis of the membranespanning domain of the human immunodeficiency virus type 1 Vpu protein. Virology 251:96-107.
45. Van Damme, N., et al. 2008. The interferon-induced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral Vpu protein. Cell Host Microbe 3:245-252.
46. Vincent, M. J., N. U. Raja, and M. A. Jabbar. 1993. Human immunodeficiency virus type 1 Vpu protein induces degradation of chimeric envelope glycoproteins bearing the cytoplasmic and anchor domains of CD4: role of the cytoplasmic domain in Vpu-induced degradation in the endoplasmic reticulum. J. Virol. 67:5538-5549.
47. Willey, R., F. Maldarelli, M. Martin, and K. Strebel. 1992. Human immunodeficiency virus type 1 Vpu protein induces rapid degradation of CD4. J. Virol. 66:7193-7200.
48. Willey, R., F. Maldarelli, M. Martin, and K. Strebel. 1992. Human immunodeficiency virus type 1 Vpu protein regulates the formation of intracellular gpl60-CD4 complexes. J. Virol. 66:226-234.
49. Willey, R. L., A. Buckler-White, and K. Strebel. 1994. Sequences present in cytoplasmic domain of CD4 are necessary and sufficient to confer sensitivity to the human immunodeficiency virus type 1 Vpu protein. J. Virol. 68:1207-1212.
50. Yao, X. J., et al. 1995. Degradation of CD4 induced by human immunodeficiency virus type 1 Vpu protein: a predicted alpha helix structure in the proximal cytoplasmic region of CD4 contributes to Vpu sensitivity. Virology 209:615-623.
51. Zufferey, R., D. Nagy, R. J. Mandel, L. Naldini, and D. Trono. 1997. Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nat. Biotechnol. 15:871-875.